Edesa Biotech (EDSA) Shares Outstanding (Entity) (2013 - 2026)
Edesa Biotech's Shares Outstanding (Entity) came in at 9.63 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 37.2% from 7.02 million a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Edesa Biotech's Shares Outstanding (Entity) was 5.68 million, up 74.8% from FY2024.
- Shares Outstanding (Entity) has increased in each of the last ten fiscal years, with a five-year compound annual growth rate of 32.8% (FY2020 to FY2025).
- Going back by fiscal year, Shares Outstanding (Entity) was 3.25 million in FY2024 (+5.6%), 3.08 million in FY2023 (+29.2%), 2.38 million in FY2022 (+25.3%) and 1.9 million in FY2021 (+38.3%).
- The fiscal Q3 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q4 2013.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 5.6% (fiscal Q4 2024) and 140.3% (fiscal Q1 2026) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Edesa Biotech | 40.56 Mn | 40.56 Mn | - | 9.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 7.02 Mn |
| Mar 31, 2025 | 5.31 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 2.87 Mn |
| Dec 31, 2022 | 2.76 Mn |
| Sep 30, 2022 | 2.38 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 2.21 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 1.89 Mn |
API Access
Edesa Biotech Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();